scispace - formally typeset
H

Han Moshage

Researcher at University Medical Center Groningen

Publications -  176
Citations -  9370

Han Moshage is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Hepatic stellate cell & Apoptosis. The author has an hindex of 50, co-authored 161 publications receiving 8420 citations. Previous affiliations of Han Moshage include University of Texas Health Science Center at Houston & University of Groningen.

Papers
More filters
Journal ArticleDOI

Nitrite and nitrate determinations in plasma: a critical evaluation.

TL;DR: Recovering nitrite and nitrate from plasma is near-quantitative (87%) and reproducible, and nitrite in whole blood is very rapidly oxidized to nitrate, and therefore plasma nitrite determination alone is meaningless.
Journal ArticleDOI

Cytokines and the hepatic acute phase response

TL;DR: The acute phase response is an orchestrated response to tissue injury, infection or inflammation, and a prominent feature of this response is the induction of acute phase proteins, which are involved in the restoration of homeostasis.
Journal ArticleDOI

Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver

TL;DR: It is concluded that endotoxin‐induced cholestasis is caused by decreased mrp2 and spgp levels, as well as an abnormal localization of these proteins, which may confer resistance to hepatocytes against cytokine‐induced metabolic stress.
Journal ArticleDOI

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.

TL;DR: It is found that PCT displayed acute phase reactant behavior in vivo after administration of both rhTNF‐α and rhIL‐6 and may be considered an acute phase protein.
Journal ArticleDOI

Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.

TL;DR: TUDCA contributes to the protection against GCDCA‐induced mitochondria‐controlled apoptosis by activating survival pathways, but independent of competition on the cell membrane, NF‐κB activation, and transcription.